Read More Pharma Industry News Can Dr. Reddy’s GLP-1 strategy position it as a key player in the global metabolic drug race? Explore Dr. Reddy’s GLP‑1 pipeline, patent strategy, and emerging market focus—can the Hyderabad-based pharma firm lead India’s metabolic drug push? byPallavi MadhirajuJuly 14, 2025